Skip to content
777 Sourcing.

Capability

clinical-stage pharmaceutical research

Suppliers
2
States & provinces
1
Countries
2

2 clinical-stage pharmaceutical research suppliers across 1 states and provinces in 2 countries. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

ADDEX PHARMACEUTICALS SA

PLAN-LES-OUATES

Addex Therapeutics is a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders. Its lead drug candidate, dipraglurant (mGlu5 negative allosteric modulator), is under evaluation for brain injury recovery including post-stroke and traumatic brain injury. It also advances GABAB PAM programs for substance use disorders and chronic cough, and holds a 20% equity interest in Neurosterix LLC.

allosteric modulator developmentdrug development

Compiled from public sources

HEMISPHERIAN AS

OSLO, Oslo

Hemispherian is a clinical-stage pharmaceutical company developing a novel class of small molecule drugs that target the TET2 enzyme as a targeted therapy for aggressive cancers. Its lead compound GLIX1 is entering clinical development for glioblastoma. The drugs work by restoring a cancer cell's normal epigenetic complement, triggering the DNA damage response and cancer cytotoxicity, and are well tolerated in normal tissues.

drug development

Compiled from public sources

Related capabilities

Other processes offered by the shops that list clinical-stage pharmaceutical research.

Browse all capabilities